What Physicians Need to Know About Obesity Medication and Side Effects
With the global epidemic of obesity showing no signs of waning, physicians should be aware of the cardiac side effects of weight-loss drugs.
Individualizing Treatment in Type 2 Diabetes
MD Magazine® Peer Exchange® recently hosted an esteemed panel in which the topic of discussion was taking the personalized approach in type 2 diabetes management.
Using PCSK9 Inhibitors to Reduce Major Cardiovascular Outcomes
Researchers have been investigating whether PCSK9 inhibitors can protect other patients at high risk for a cardiovascular event.
